Involvement of Src family protein tyrosine kinases in Ca2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway

Circulation Research

Volumn 91, Issue 10, 2002, Pages 953-960

  Nakao, Fumiaki ^a   Kobayashi, Sei ^a   Mogami, Kimiko ^a   Mizukami, Yoichi ^a   Shirao, Satoshi ^a   Miwa, Saori ^a   Todoroki Ikeda, Natsuko ^a   Ito, Masaaki ^b   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+ sensitization; Eicosapentaenoic acid; S palmitoylation; Sphingosylphosphorylcholine; Src family protein tyrosine kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM SENSITIZER; ICOSAPENTAENOIC ACID; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE; RHO KINASE; SPHINGOSYLPHOSPHORYLCHOLINE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; DEPOLARIZATION; DRUG ACTIVITY; ENZYME ACTIVITY; IMMUNOCYTOCHEMISTRY; INTRACELLULAR TRANSPORT; MALE; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; RAT; SENSITIZATION;

ACYLATION; ANIMALS; BLOTTING, WESTERN; CALCIUM; CORONARY VESSELS; ENZYME ACTIVATION; ENZYME INHIBITORS; FATTY ACIDS, UNSATURATED; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOMETRIC CONTRACTION; MALE; MUSCLE, SMOOTH, VASCULAR; PALMITATES; PHOSPHORYLCHOLINE; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; SPHINGOSINE; SRC-FAMILY KINASES; SWINE; VASOCONSTRICTION;

EID: 0037112412     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000042702.04920.BF     Document Type: Article

References (40)

1. Liliom K, Sun G, Bunemann M, Virag T, Nusser N, Baker DL, Wang DA, Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G, Pott L. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: A possible role in regulating cardiac function via sphingolipid receptors. Biochem J. 2001;355:189-197.
2. Sachinidis A, Kettenhofen R, Seewald S, Gouni-Berthold I, Schmitz U, Seul C, Ko Y, Vetter H. Evidence that lipoproteins are carriers of bioactive factors. Arterioscler Thromb Vasc Biol. 1999;19:2412-2421.
3. 2+-sensitization of vascular smooth muscle contraction: Possible involvement of Rho-kinase. FEBS Lett. 2000;482:85-90.
4. 2+ sensitization in the bovine cerebral artery: Unimportant role for protein kinase C. Circ Res. 2002;91:112-119.
5. 2+ sensitization. Circ Res. 2002;91:83-84.
6. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrythmias, and sudden death in patients with vasospastic angina. Circulation. 1987;75:1110-1116.
7. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988;78:1-9.
8. Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 2000;87:195-200.
9. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabayashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, Takeshita A. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999;43:1029-1039.
10. Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, Takai Y. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem. 1992;267:8719-8722.
11. Kimura K, Ito M, Amano M, Chihara K Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science. 1996;273:245-248.
12. Taggart MJ, Lee YH, Morgan KG. Cellular redistribution of PKCα, rhoA, and ROKα following smooth muscle agonist stimulation. Exp Cell Res. 1999;251:92-101.
13. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem. 1999;274:37385-37390.
14. Nagao M, Kaziro Y, Itoh H. The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Gα12. Oncogene. 1999;18:4425-4434.
15. Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. Cysteine 3 of Src family protein tyrosine kinases determines palmitoylation and localization in caveolae. J Cell Biol. 1994;126:353-363.
16. Alland L, Peseckis SM, Atherton RE, Berthiaume L, Resh MD. Dual myristoylation and palmitoylation of Src family member p59fyn affects subcellular localization. J Biol Chem. 1994;269:16701-16705.
17. Yurchak LK, Sefton BM. Palmitoylation of either Cys-3 or Cys-5 is required for the biological activity of the Lck tyrosine protein kinase. Mol Cell Biol. 1995;15:6914-6922.
18. Stulnig TM, Berger M, Sigmund T, Raederstorff D, Stockinger H, Waldhausl W. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol. 1998;143:637-644.
19. Venema RC, Venema VJ, Eaton DC, Marrero MB. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1. J Biol Chem. 1998;273:30795-30800.
20. Sayeski PP, Ali MS, Safavi A, Lyles M, Kim SO, Frank SJ, Bernstein KE. A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn. J Biol Chem. 1999;274:33131-33142.
21. 2+ elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery. FEBS Lett. 1999;457:375-380.
22. Miermont AM, Mohamed AS, Swope SL. Generation of phosphorylation state-specific SRC-class kinase antibodies for analysis of kinase activation. J Immunol Methods. 2000;246:203-215.
23. Kobayashi S, Kanaide H, Nakamura M. Cytosolic-free calcium transients in cultured vascular smooth muscle cells: Microfluorometric measurements. Science. 1985;229:553-556.
24. Kanaide H, Kobayashi S, Nishimura J, Hasegawa M, Shogakiuchi Y, Matsumoto T, Nakamura M. Quin2 microfluorometry and effects of verapamil and diltiazem on calcium release from rat aorta smooth muscle cells in primary culture. Circ Res. 1988;63:16-26.
25. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res. 1996;79:14-19.
26. 2+-independent activation and translocation of endothelial nitric oxide (NO) synthase and endothelium-dependent vasorelaxation. FEBS Lett. 2001;487:361-366.
27. Khalil RA, Morgan KG. Imaging of protein kinase C distribution and translocation in living vascular smooth muscle cells. Circ Res. 1991;69:1626-1631.
28. Webb Y, Hermida-Matsumoto L, Resh MD. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem. 2000;275:261-270.
29. Imamoto A, Soriano P. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell. 1993;73:1117-1124.
30. Thomas SM, Soriano P, Iwamoto A. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature. 1995;376:267-271.
31. Cobb BS, Schaller MD, Leu TH, Parsons JT. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol. 1994;14:147-155.
32. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: Study of Lck- and FynT-dependent T cell activation. J Biol Chem. 1996;271:695-701.
33. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens. 2001;19:441-449.
34. Johnson DR, Bhatnagar RS, Knoll LJ, Gordon JI. Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem. 1994;63:869-914.
35. Wilcox C, Hu JS, Olson EN. Acylation of proteins with myristic acid occurs cotranslationally. Science. 1987;238:1275-1278.
36. Roseth S, Fykse EM, Fonnum F. The effect of arachidonic acid and free fatty acids on vesicular uptake of glutamate and γ-aminobutyric acid. Eur J Pharmacol. 1998;341:281-288.
37. 2+ sensitization of smooth muscle contraction through activation of Rho-kinase. Pflugers Arch. 2001;441:596-603.
38. Inoue I, Noji S, Shen MZ, Takahashi K, Katayama S. The peroxisome proliferator-activated receptor a (PPARα) regulates the plasma thiobarbituric acid-reactive substance (TBARS) level. Biochem Biophys Res Commun. 1997;237:606-610.
39. Wakino S, Kintscher U, Liu Z, Kim S, Yin F, Ohba M, Kuroki T, Schonthal AH, Hsueh WA, Law RE. Peroxisome proliferator-activated receptor γ ligands inhibit mitogenic induction of p21(CipI) by modulating the protein kinase Cδ pathway in vascular smooth muscle cells. J Biol Chem. 2001;276:47650-47657.
40. Young ME, Laws FA, Goodwin GW, Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor a is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem. 2001;276:44390-44395.